<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03227380</url>
  </required_header>
  <id_info>
    <org_study_id>THO-2016-01</org_study_id>
    <nct_id>NCT03227380</nct_id>
  </id_info>
  <brief_title>Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy</brief_title>
  <official_title>Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Mutualiste Montsouris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Mutualiste Montsouris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine whether stapling adversely affects the pulmonary&#xD;
      parenchyma and the vascularisation of the adjacent segments. The aim of our work is to&#xD;
      explore by thoracic densitometry with contrast the spared segments after stapling of the&#xD;
      intersegmental plan following a thoracoscopic segmentectomy, 3 or 6 months post-surgery. the&#xD;
      investigator will assess venous drainage and the arterial vascularisation of the remaining&#xD;
      segments, possible modifications of the adjacent parenchyma and whether there is a defect of&#xD;
      pleuro-pulmonary adhesion (residual pneumothorax).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Scheduled anatomical segmentectomies are increasingly popular, due to the development of&#xD;
      minimally invasive techniques, the increased incidence of early-stage tumours, and the&#xD;
      possibility of caring for patients with compromised health and/or limited respiratory&#xD;
      function without compromising the oncological outcome, compared to current alternatives such&#xD;
      as stereotactic ablative radiotherapy (1).&#xD;
&#xD;
      One of the challenges in the development of the thoracoscopic segmentectomy technique we have&#xD;
      published (2-5) is the orientation (6-7) and the division of the intersegmental plane, by&#xD;
      contrast to segmentectomy by thoracotomy where this is helped by palpation and the manual&#xD;
      traction which can be used on the segment, along the intersegmental vein. The most commonly&#xD;
      used technique to separate two adjacent segments remains stapling, despite its high cost and&#xD;
      sometimes giving a less anatomical section, with a risk to encroach on the intersegmental&#xD;
      vein. Moreover, there can be a partial plicator of the spared segment(s) which could in&#xD;
      theory make them less functional.&#xD;
&#xD;
      We have however shown that the postoperative morbidity and mortality rates were much lower&#xD;
      than that of patients who had a thoracotomy, dropping from 42% for thoracotomies to 16% for&#xD;
      thoracoscopies, the surgical approach being an independent predictive factor for&#xD;
      postoperative complications (8).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">March 31, 2017</start_date>
  <completion_date type="Anticipated">August 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">February 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>patients undergo anatomic segmentectomy by video-assisted thoracoscopic surgery (VATS)</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The measure of the remaining segments after stapling the intersegmental plane by injected CT scan</measure>
    <time_frame>3 or 6 months after surgery</time_frame>
    <description>The aim of investigators work is to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy, from 3 to 6 months post-surgery. The investigators will assess venous drainage and the arterial vascularisation of the remaining segments, possible modifications of the adjacent parenchyma and whether there is a defect of pleuro-pulmonary adhesion (residual pneumothorax).&#xD;
The radiological evaluation criteria will be:&#xD;
Presence and quantification of a defect in pulmonary expansion (residual pneumothorax)&#xD;
Abnormal venous and arterial vascularisation of the remaining segments&#xD;
Defect of the pulmonary parenchyma in contact with the staples line (atelectasis, vascularisation defect)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Video-assisted Thoracoscopic Surgery (VATS)</condition>
  <condition>Segmentectomy</condition>
  <arm_group>
    <arm_group_label>radiological evaluation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>thoracic densitometry with contrast</intervention_name>
    <description>injected CT scan at 3 or 6 months after segmentectomy VATS</description>
    <arm_group_label>radiological evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Enrolment in the study will be offered to all patients having undergone a programmed&#xD;
             scheduled video-assisted thoracoscopic segmentectomy, whatever the aetiology.&#xD;
&#xD;
          -  Men or women aged 18 years or greater&#xD;
&#xD;
          -  Absence of severe hepatic insufficiency&#xD;
&#xD;
          -  signed and dated informed consent&#xD;
&#xD;
          -  candidate for segmentectomy&#xD;
&#xD;
          -  Registration in a national healthcare system.&#xD;
&#xD;
          -  Women of child-bearing age using effective oral or barrier contraception&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Proven intolerance to iodinated contrast agents&#xD;
&#xD;
          -  Know allergy or non-controlled asthma - pregnancy&#xD;
&#xD;
          -  Severe hepatic insufficiency (creatinine clearance &lt; 30ml/min, by Cockroft's method)&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Patients under trusteeship or curators&#xD;
&#xD;
          -  Diabetic patients or patients receiving oral antidiabetic medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Agathe SEGUIN-GIVELET, MD</last_name>
    <phone>0156616240</phone>
    <email>agathe.seguin-givelet@imm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut Mutualiste montsouris</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institut mutualiste montsouris</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle SAURET</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>June 19, 2017</study_first_submitted>
  <study_first_submitted_qc>July 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2017</study_first_posted>
  <last_update_submitted>July 21, 2017</last_update_submitted>
  <last_update_submitted_qc>July 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

